09/18/2024
3:16 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:17 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:17 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:18 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:18 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
6:06 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
5:41 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
09/16/2024
5:22 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:37 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:15 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:24 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
3:23 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024
3:15 PM | Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
Weber Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
3:48 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
4:34 PM | Clyburn Frank (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/07/2024
4:34 PM | Clyburn Frank (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
4:07 PM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 424B5 | |
08/02/2024
4:35 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
3:29 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
4:05 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
3:27 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
7:03 AM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
3:35 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:36 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:36 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
3:36 PM | Patel Sushil (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
3:36 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
3:19 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024
3:19 PM | Patel Sushil (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024
4:05 PM | Horning Sandra (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4/A | |
06/28/2024
4:06 PM | Patel Sushil (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4/A | |
06/28/2024
4:06 PM | Borisy Alexis (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4/A | |
06/28/2024
4:07 PM | Kim Lorence H. (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4/A | |
06/28/2024
4:07 PM | Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
Weber Barbara (Reporting)
| Form 4/A | |
06/28/2024
4:08 PM | Borellini Flavia (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4/A | |
06/28/2024
4:09 PM | ANDERSON ELIZABETH M (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4/A | |
06/27/2024
5:48 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
3:20 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024
3:20 PM | ANDERSON ELIZABETH M (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
3:20 PM | Borellini Flavia (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
3:20 PM | Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
Weber Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Jovine Was Right in 2008—Will You Listen This Time? (Ad) The stock market collapsed and didn't recover for an entire decade.
And what we're facing today could be even worse.
That's why the actions you take in the next 90 days could be crucial for your financial future. Take these 4 steps today to protect your retirement NOW |
06/24/2024
3:21 PM | Kim Lorence H. (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
3:21 PM | Borisy Alexis (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
3:22 PM | Patel Sushil (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
3:23 PM | Horning Sandra (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
10:28 AM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
4:47 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
4:37 PM | Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
Wei Lin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
4:20 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
4:08 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
3:56 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
3:31 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
3:18 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:40 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/21/2024
3:31 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024
4:11 PM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form S-3ASR | |
05/03/2024
6:36 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2024
3:30 PM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form DEF 14A | |
04/25/2024
3:35 PM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form DEFA14A | |
04/12/2024
7:08 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
3:23 PM | Patel Sushil (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:21 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
3:21 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
3:21 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
3:21 PM | Patel Sushil (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/29/2024
3:57 PM | Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
Wei Lin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
3:24 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
3:43 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
3:44 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
3:44 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
3:45 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
3:45 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
4:50 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
4:10 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
4:21 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
4:04 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
3:48 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024
3:32 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:30 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
3:52 PM | Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
Wang Xiaolin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:53 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:54 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:54 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:55 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:30 PM | EcoR1 Capital, LLC (Filed by)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form SC 13G/A | |
02/14/2024
8:26 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form SC 13G/A | |
02/13/2024
5:06 AM | BB BIOTECH AG (Filed by)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form SC 13G/A | |
02/12/2024
4:11 PM | Farallon Capital Partners, L.P. (Filed by)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form SC 13G/A | |
02/09/2024
4:22 PM | COLUMN GROUP III, LP (Filed by)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form SC 13G/A | |
02/08/2024
9:17 AM | Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/22/2024
3:18 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Retire off just one stock ticker? (Ad) ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now.
They will NOT make you rich. However, there is one stock that stands head and shoulders above everything else.
It's currently trading for only $15... Click here for the ticker >>> |
01/10/2024
3:26 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
1:15 PM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:06 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
3:31 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/29/2023
3:14 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
3:22 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
4:07 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
4:08 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
4:08 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
